
**DISASTER ACTION 1180287 Receipts and payments accounts CC16a For the period** 11/1/2022 10/31/2023 **To** 

**For the period from** 

## **Section A Receipts and payments** 

**Unrestricted Restricted Endowment funds funds funds** 

## **Total funds Last year** 

**to the nearest      £** 

**to the nearest £ to the nearest £ to the nearest £ to the nearest £** 

## **A1 Receipts** 

|**A1 Receipts**|||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
||**-**||**-**||**-**||**-**||**-**||
||**-**||**-**||**-**||**-**||**-**||
||**-**||**-**||**-**||**-**||**-**||
||**-**||**-**||**-**||**-**||**-**||
||**-**||**-**||**-**||**-**||**-**||
||**-**||**-**||**-**||**-**||**-**||
||**-**||**-**||**-**||**-**||**-**||
||**-**||**-**||**-**||**-**||**-**||
|**_Sub total_**_(Gross income for AR)_|**-**<br>||**-**||**-**||**-**||**-**||



|**A1 Receipts**|||||||||
|---|---|---|---|---|---|---|---|---|
||**-**||**-**||**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**|**-**||**-**|
||**-**||**-**|||**-**||**-**|
||**-**||**-**|||**-**||**-**|
||**-**||**-**|||**-**||**-**|
||**-**||**-**|||**-**||**-**|
||**-**||**-**|||**-**||**-**|
||**-**||**-**|||**-**||**-**|
||**-**||**-**|||**-**||**-**|
|**_Sub total_**_(Gross income for AR)_|**-**<br>||**-**|||**-**||**-**|
|**-**<br>**-**<br>**_Sub total_                              -**<br>**_Total receipts_                           -**<br>**A3 Payments**<br>**188**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**_Sub total_                          188**<br>**-**<br>**-**<br>**_Sub total_                               -**<br>**_Total payments_                      188**<br>**_Net of receipts/(payments)_ -                    188**<br>**A5 Transfers between funds**<br>**-**<br>**A6 Cash funds last year end**<br>**16,156**<br>**_Cash funds this year end_                  15,968**<br>**A2 Asset and investment sales,**<br>**(see table).**<br>**A4 Asset and investment**<br>**purchases, (see table)**|||**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**|||**-**<br>**-**<br>**-**<br>**-**<br>**188**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**188**<br>**-**<br>**-**<br>**-**<br>**188**<br>**-                    188**<br>**-**<br>**16,156**<br>**15,968**|||
||||||**-**<br>**-**<br>**-**|**-**|||
|||||||**-**||**-**|
|||||||**-**||**-**|
||||||||||
||||||**-**|**-**||**-**|
||||||||||
||||||**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**|**188**||**-**|
|||||||**-**||**-**|
|||||||**-**||**-**|
|||||||**-**||**-**|
|||||||**-**||**-**|
|||||||**-**||**-**|
|||||||**-**||**-**|
|||||||**-**||**-**|
|||||||**-**||**-**|
|||||||**188**||**-**|
||||||||||
||||||**-**<br>**-**<br>**-**|**-**|||
|||||||**-**|||
|||||||**-**||**-**|
||||||||||
||||||**-**|**188**||**-**|
||||||||||
||||**-**||**-**<br>**-**<br>**-**<br>**-**|**-                    188**||**-**|
||||**-**|||**-**||**-**|
||||**-**|||**16,156**||**-**|
||||**-**|||**15,968**||**-**|





|**Section B Statement of assets and liabilities at the end of the period**|**Section B Statement of assets and liabilities at the end of the period**|**Section B Statement of assets and liabilities at the end of the period**||
|---|---|---|---|
|**Categories**<br>**B1 Cash funds**<br>**B2 Other monetary assets**<br>**B3 Investment assets**<br>**B5 Liabilities**<br>**B4 Assets retained for the**<br>**charity’s own use**<br>Signed by one or two trustees on<br>behalf of all the trustees|**Details**<br>**Details**<br>**Details**<br>**Details**<br>**Details**<br>Sophie Tarassenko<br>**_Total cash funds_**<br>(agree balances with receipts and payments<br>account(s))|**to nearest £**<br>**to nearest £**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**15,968**<br>**-**<br>OK<br>OK<br>**to nearest £**<br>**to nearest £**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**Cost (optional)**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**Cost (optional)**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>SOPHIE TARASSENKO<br>**Unrestricted**<br>**funds**<br>**Restricted**<br>**funds**<br>**Unrestricted**<br>**funds**<br>**Restricted**<br>**funds**<br>**Fund to which**<br>**asset belongs**<br>**Fund to which**<br>**asset belongs**<br>**Fund to which**<br>**liability relates**<br>**Amount due**<br>**(optional)**|**to nearest £**<br>**Endowment**<br>**funds**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||OK|
||||**to nearest £**<br>**Endowment**<br>**funds**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**Current value**<br>**(optional)**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**Current value**<br>**(optional)**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**When due**<br>**(optional)**|
|||||
|||||
|||||
|||||
|||||
|||||
||||9/2/2024|
|||||
|||||



